These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37940856)

  • 1. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
    Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
    J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
    Matharu M; Katsarava Z; Buse DC; Sommer K; Reed ML; Fanning KM; Lipton RB
    Headache; 2024; 64(7):750-763. PubMed ID: 38982663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
    Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most Bothersome Symptom in Persons With Migraine: Results From the Migraine in America Symptoms and Treatment (MAST) Study.
    Munjal S; Singh P; Reed ML; Fanning K; Schwedt TJ; Dodick DW; Buse DC; Lipton RB
    Headache; 2020 Feb; 60(2):416-429. PubMed ID: 31837007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
    Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
    Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.
    Lanteri-Minet M; Leroux E; Katsarava Z; Lipton RB; Sakai F; Matharu M; Fanning K; Manack Adams A; Sommer K; Seminerio M; Buse DC
    J Headache Pain; 2024 Aug; 25(1):134. PubMed ID: 39160483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study.
    Katsarava Z; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Adams AM; Carr K; Fanning KM; Lipton RB
    Cephalalgia; 2024 Aug; 44(8):3331024241274343. PubMed ID: 39175365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
    Lipton RB; Pozo-Rosich P; Orr SL; Reed ML; Fanning KM; Dabruzzo B; Buse DC
    Headache; 2023; 63(10):1448-1457. PubMed ID: 37795746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pre-morbid headaches on headache features and long-term health outcomes following traumatic brain injury: Insights from the American Registry for Migraine Research.
    Leibovit-Reiben Z; Ishii R; Dodick DW; Dumkrieger G; Cortez MM; Brennan KC; Digre K; Schwedt TJ
    Headache; 2022 May; 62(5):566-576. PubMed ID: 35593782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study.
    Schwedt TJ; Alam A; Reed ML; Fanning KM; Munjal S; Buse DC; Dodick DW; Lipton RB
    J Headache Pain; 2018 May; 19(1):38. PubMed ID: 29797100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study.
    Buse DC; Reed ML; Fanning KM; Bostic R; Dodick DW; Schwedt TJ; Munjal S; Singh P; Lipton RB
    J Headache Pain; 2020 Mar; 21(1):23. PubMed ID: 32122324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
    Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
    Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of allodynia in persons with migraine: Results from the Migraine in America Symptoms and Treatment (MAST) study.
    Dodick DW; Reed ML; Fanning KM; Munjal S; Alam A; Buse DC; Schwedt TJ; Lipton RB
    Cephalalgia; 2019 Jun; 39(7):873-882. PubMed ID: 30732460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study.
    Lipton RB; Munjal S; Buse DC; Alam A; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2019 Sep; 59(8):1310-1323. PubMed ID: 31410844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication Overuse and Headache Burden: Results From the CaMEO Study.
    Schwedt TJ; Buse DC; Argoff CE; Reed ML; Fanning KM; Hussar CR; Adams AM; Lipton RB
    Neurol Clin Pract; 2021 Jun; 11(3):216-226. PubMed ID: 34476122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Seng EK; Chu MK; Reed ML; Fanning KM; Adams AM; Buse DC
    Headache; 2020 Sep; 60(8):1683-1696. PubMed ID: 33448374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.